|Day Low/High||36.37 / 36.81|
|52 Wk Low/High||33.97 / 46.47|
Pfizer Inc. (NYSE:PFE) today announced it plans to invest $600 million in biotechnology and other emerging growth companies through Pfizer Ventures, the company's venture investment vehicle.
Pfizer Inc. (NYSE:PFE) today announced overall survival (OS) data from the ARCHER 1050 trial evaluating dacomitinib as a first-line treatment for patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) with EGFR-activating...
After a lot of patience and disappointment, we are closing our remaining small 'spec' position.
Pfizer Inc. (NYSE:PFE) today announced the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion, recommending marketing authorization for TRAZIMERA™, a potential biosimilar to...
Following up on a pledge to accelerate generic drugs into the marketplace to stoke price competition, the agency signals pending reform of the Risk Evaluation and Mitigation Strategy.
Pfizer Inc. (NYSE:PFE) announced today that the U.
President Trump's appetite for TV and ratings is legendary and now the administration wants to require drug company TV ads to include the list price of prescription drugs.
Options spreads aren't tradable with some small biotechs, making shares the only way to play.
Pfizer Inc. (NYSE:PFE) announced today that tafamidis received Breakthrough Therapy designation from the US Food and Drug Administration (FDA) for the treatment of patients with transthyretin cardiomyopathy, a rare, fatal, and underdiagnosed condition...
Pfizer Inc. (NYSE: PFE) announced today that results from a study analyzing real-world effectiveness data found that Prevnar 13 ® (pneumococcal 13-valent conjugate vaccine [diphtheria CRM 197 Protein]) reduced the risk of hospitalization from vaccine-type...
Pfizer Inc. (NYSE:PFE) today announced that it has started a Phase 1/2 trial of its respiratory syncytial virus (RSV) vaccine candidate in healthy adult volunteers.
Following up on President Trump's drug pricing speech last week, the FDA posted a list of 39 name-brand drug firms that are allegedly making life tough on generic drug companies.
Why study charts? Because they're like footprints at the scene of the crime, clues to what the big money managers are likely thinking, Jim Cramer says.
Invacare Corporation (NYSE: IVC) today announced the appointment of Petra Danielsohn-Weil, PhD, to its Board of Directors, effective May 17, 2018.
Pfizer Inc. (NYSE: PFE) announced today positive top-line results of a Phase 3 study examining the use of LYRICA ® (pregabalin) Oral Solution CV as adjunctive therapy for partial onset seizures in pediatric epilepsy patients one month to less than four...
Pfizer Inc. today announced that new data from its diversified portfolio of marketed and investigational oncology medicines will be presented at the 54 th Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago from June 1-5, 2018.
Pfizer Inc. (NYSE:PFE) today announced the United States (U.
These three "strong buy" biotech stocks are primed for outsized growth in the next 12 months. Here's why.
President Trump reduced tensions in Korea, raised them in the Middle East, and mainly relieved them for investors in the drug and healthcare industries.
President Trump delivered a highly-anticipated speech on lowering the cost of drugs for Americans on Friday afternoon.
The EpiPen maker saw a 19% drop in North America net sales due in part to lower sales of branded products.
The most recent short interest data has been released for the 04/13/2018 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Dow Jones Industrial Average by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.
A study of analyst recommendations at the major brokerages shows that Pfizer Inc is the #15 broker pick, on average, out of the 30 stocks making up the Dow Jones Industrial Average, according to ETF Channel. Within the broader S&P 500, when components were ranked in terms of analyst favorites, PFE claims the #235 spot.
Stocks were mixed on Tuesday with investors adopting a cautious stance as the Federal Reserve begins a two-day meeting.
U.S. stock futures are mixed as the Federal Reserve kicks off a two-day meeting and Apple is scheduled to report quarterly results.
Global stocks bumped higher Tuesday, while oil prices held at three-and-a-half year highs, amid several key market closures and ahead of what could be a crucial quarterly earnings update from Apple after the close of trading.
I think it very possible that there will be a positive reaction tonight, more likely based on what Tim Cook says.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.